Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to FREE Stock Alerts by visiting: http://www.pennystockpickreport.com/
Mylan Inc. (NASDAQ:MYL) climbed 5% to $16.54 after it reported a third-quarter net loss of $40 million, or 13 cents a share, compared to profit of $182.4 million, or 47 cents a share, in the same period a year ago. On an adjusted basis, the Pittsburgh-based drugmaker said third-quarter profit totaled $142.3 million, or 32 cents a share. A survey of analysts by FactSet Research produced a consensus forecast for a profit of 27 cents a share. The company reported total third-quarter revenues of $1.26 billion, down from $1.66 billion. The company raised its forecast for full-year 2009 earnings to a range of $1.24 to $1.28 a share, up from a previous range of $1.13 to $1.20 a share.
Mylan Inc. (Mylan) and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients (API). As of
ABOUT PennyStockPickReport.com
Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. These include various types of stocks with huge volume, penny stocks that are moving to the upside quickly, penny stocks with buy signals and companies with news. Our regular Stock Alerts helps investors to achieve incredible results in a short amount of time and our members have made remarkable profits of over 100%.